Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 059186/0374 | |
| Pages: | 6 |
| | Recorded: | 03/07/2022 | | |
| Attorney Dkt #: | ACU-22 -1071CON ET AL. |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
5
|
|
|
|
Patent #:
|
|
Issue Dt:
|
04/26/2016
|
Application #:
|
14790113
|
Filing Dt:
|
07/02/2015
|
|
Publication #:
|
|
Pub Dt:
|
12/31/2015
| | | | |
|
Title:
|
METHODS AND COMPOSITIONS FOR SELF-REGULATED RELEASE OF ACTIVE PHARMACEUTICAL INGREDIENT
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
05/30/2017
|
Application #:
|
15074458
|
Filing Dt:
|
03/18/2016
|
|
Publication #:
|
|
Pub Dt:
|
07/14/2016
| | | | |
|
Title:
|
METHODS AND COMPOSITIONS FOR SELF-REGULATED RELEASE OF ACTIVE PHARMACEUTICAL INGREDIENT
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
10/15/2019
|
Application #:
|
15588982
|
Filing Dt:
|
05/08/2017
|
|
Publication #:
|
|
Pub Dt:
|
08/24/2017
| | | | |
|
Title:
|
METHODS AND COMPOSITIONS FOR SELF-REGULATED RELEASE OF ACTIVE PHARMACEUTICAL INGREDIENT
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
06/23/2020
|
Application #:
|
16041331
|
Filing Dt:
|
07/20/2018
|
|
Publication #:
|
|
Pub Dt:
|
11/15/2018
| | | | |
|
Title:
|
METHODS AND COMPOSITIONS FOR SELF-REGULATED RELEASE OF ACTIVE PHARMACEUTICAL INGREDIENT
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
08/10/2021
|
Application #:
|
16899529
|
Filing Dt:
|
06/11/2020
|
|
Publication #:
|
|
Pub Dt:
|
12/03/2020
| | | | |
|
Title:
|
METHODS AND COMPOSITIONS FOR SELF-REGULATED RELEASE OF ACTIVE PHARMACEUTICAL INGREDIENT
|
|
|
Assignee
|
|
|
|
|
| 616 N. NORTH COURT |
| #120 |
| PALATINE, ILLINOIS 60067 |
|
|
Correspondence name and address
|
| |
IP GROUP OF DLA PIPER LLP (US)
|
| |
ONE LIBERTY PLACE
|
| |
1650 MARKET ST. SUITE 5000
|
| |
PHILADELPHIA, PA 19103
|
Search Results as of:
05/03/2024 02:17 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
